11 Mar 14:00
Medivir outlicenses MIV-210 to Daewoong Pharmaceutical Co. Ltd. for clinical development
26 Feb 11:15
Increased number of shares and votes in Medivir
Latest reports
FINANCIAL STATEMENT, 1 JANUARY – 31 DECEMBER 2009
INTERIM REPORT, 1 JANUARY – 30 SEPTEMBER 2009
Forthcoming reports 2010
The Three-month Interim Report will be published on 29 April
The Annual General Meeting will be held on 29 April
The Six-month Interim Report will be published on 8 July
The Nine-month Interim Report will be published on 22 October
